HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jalal Alali Selected Research

Therapeutics

12/2022Efficacy and Safety of Tixagevimab/Cilgavimab to Prevent COVID-19 (Pre-Exposure Prophylaxis): A Systematic Review and Meta-Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jalal Alali Research Topics

Disease

2COVID-19
12/2022 - 12/2021
1Multiple Organ Failure (MODS)
12/2021
1Pneumothorax
12/2021
1Pulmonary Embolism
12/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
12/2021
1Septic Shock (Toxic Shock Syndrome)
12/2021
1Critical Illness (Critically Ill)
12/2021
1Hemorrhage
12/2021

Drug/Important Bio-Agent (IBA)

1tixagevimabIBA
12/2022
1COVID-19 VaccinesIBA
12/2022
1cilgavimabIBA
12/2022
1Oxygen (Dioxygen)IBA
12/2022

Therapy/Procedure

1Contraindications
12/2022
1Therapeutics
12/2022
1Extracorporeal Membrane Oxygenation
12/2021
1Artificial Respiration (Mechanical Ventilation)
12/2021
1Blood Transfusion (Blood Transfusions)
12/2021